What is AEON Biopharma, Inc.?
, a clinical stage biopharmaceutical company, focuses on developing botulinum toxins.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical stage biopharmaceutical company, focuses on developing botulinum toxins. It develops ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, which completed Phase 2 study for the treatment of cervical dystonia and has an ongoing Phase 2 study for the treatment of chronic and episodic migraine. The company is listed on the AMEX in USA, operating in the Healthcare sector, with a market capitalisation of 10.35M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 3441,885 shares $57k |
| 3-6months | 0 | 11,150,000 shares $243k |
| 6-9months | 0 | 0 |
| 9-12months | 0 | 0 |